This week’s roundup examines medication safety in pregnancy, postpartum depression treatments, opioid and cannabis use, and emerging research on women’s ADHD.
Read the Latest News
Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.
A new cohort study from Australia found that lithium use during pregnancy was linked to a two-fold increased risk of spontaneous preterm birth, along with higher risks of a large for gestational age infant and congenital cardiac malformations. We review how these findings compare with prior research and what they mean for women with bipolar disorder who are using — or considering — lithium during pregnancy.
New prospective data on 56 first-trimester vortioxetine exposures found no major malformations, offering reassuring but still preliminary reproductive safety information.
This week’s roundup discusses the impact of hormonal contraception on mood and covers new data on the use of ADHD medications, antidepressants, and antipsychotics during pregnancy.
Sign up for our newsletter
Get the latest news in women’s mental health and our research.
"*" indicates required fields
